Pharmacotherapy in Coronavirus Disease 2019 and Risk of Secondary Infections: A Single-Center Case Series and Narrative Review

Pharmacotherapy in Coronavirus Disease 2019 and Risk of Secondary Infections: A Single-Center Case Series and Narrative Review

OBJECTIVES:. Since the onset of the coronavirus disease 2019 pandemic, immune modulators have been considered front-line candidates for the management of patients presenting with clinical symptoms secondary to severe acute respiratory syndrome coronavirus 2 infection. Although heavy emphasis has bee...

Full description

Bibliographic Details
Main Authors: Michael Behal, PharmD, Brooke Barlow, PharmD, Breanne Mefford, PharmD, BCCCP, Melissa L. Thompson Bastin, PharmD, PhD, BCPS, J. Chris Donaldson, PharmD, BCCCP, Melanie Laine, PharmD, BCCCP, Brittany D. Bissell, PharmD, PhD, BCCCP
Format: Article
Language:English
Published: Wolters Kluwer 2021-07-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000492

Internet

http://journals.lww.com/10.1097/CCE.0000000000000492

Similar Items